» Articles » PMID: 38318919

Cell-based Vs Enzyme-linked Immunosorbent Assay for Detection of Anti-Tribbles Homolog 2 Autoantibodies in Chinese Patients with Narcolepsy

Overview
Specialties Neurology
Psychiatry
Date 2024 Feb 6
PMID 38318919
Authors
Affiliations
Soon will be listed here.
Abstract

Study Objectives: Narcolepsy type 1 is attributed to a deficiency in cerebrospinal fluid orexin and is considered linked to autoimmunity. The levels of anti-Tribbles homolog 2 (TRIB2) autoantibodies are elevated in the sera of some patients with narcolepsy with cataplexy. Additionally, injecting mice with serum immunoglobulin from patients with narcolepsy with positive anti-TRIB2 antibodies can induce hypothalamic neuron loss and alterations in sleep patterns. Consequently, we hypothesized the existence of a potential association between anti-TRIB2 antibodies and narcolepsy. To test this possibility, we used cell-based assays (CBAs) and enzyme-linked immunosorbent assays (ELISAs) to detect the presence of anti-TRIB2 antibodies in Chinese patients with narcolepsy.

Methods: We included 68 patients with narcolepsy type 1, 39 patients with other central disorders of hypersomnolence, and 43 healthy controls. A CBA and a conventional ELISA were used to detect anti-TRIB2 antibody levels in patients' sera.

Results: CBA was used to detect serum anti-TRIB2 antibodies in Chinese patients with narcolepsy, and the results were negative. However, when the ELISA was used, only 2 patients with narcolepsy type 1 had TRIB2 antibody titers higher than the mean titer plus 2 standard deviations of the healthy controls.

Conclusions: In our study, ELISA identified TRIB2 autoantibodies in sera of patients with narcolepsy where CBA failed to demonstrate them. Contrary to our hypothesis, this intriguing finding deserves further research to elucidate the potential association between TRIB2 and narcolepsy type 1. Exploring the implications of TRIB2 autoantibodies in narcolepsy and disparate outcomes between ELISA and CBA could provide crucial insights.

Citation: Zhong X, Yuan Y, Zhan Q, et al. Cell-based vs enzyme-linked immunosorbent assay for detection of anti-Tribbles homolog 2 autoantibodies in Chinese patients with narcolepsy. . 2024;20(6):941-946.

References
1.
Yan C, Li W, Song J, Feng X, Xi J, Lu J . Cell-Based Versus Enzyme-Linked Immunosorbent Assay for the Detection of Acetylcholine Receptor Antibodies in Chinese Juvenile Myasthenia Gravis. Pediatr Neurol. 2019; 98:74-79. DOI: 10.1016/j.pediatrneurol.2019.01.016. View

2.
Rodriguez Cruz P, Huda S, Lopez-Ruiz P, Vincent A . Use of cell-based assays in myasthenia gravis and other antibody-mediated diseases. Exp Neurol. 2015; 270:66-71. DOI: 10.1016/j.expneurol.2015.01.011. View

3.
Waters P, McKeon A, Leite M, Rajasekharan S, Lennon V, Villalobos A . Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology. 2012; 78(9):665-71. PMC: 3286228. DOI: 10.1212/WNL.0b013e318248dec1. View

4.
Mayoral-Varo V, Jimenez L, Link W . The Critical Role of TRIB2 in Cancer and Therapy Resistance. Cancers (Basel). 2021; 13(11). PMC: 8198994. DOI: 10.3390/cancers13112701. View

5.
van Coevorden-Hameete M, Titulaer M, Schreurs M, de Graaff E, Sillevis Smitt P, Hoogenraad C . Detection and Characterization of Autoantibodies to Neuronal Cell-Surface Antigens in the Central Nervous System. Front Mol Neurosci. 2016; 9:37. PMC: 4885853. DOI: 10.3389/fnmol.2016.00037. View